Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are over 18 years old
- People who have had their first stroke affecting one side of the brain, with the stroke occurring more than 3 months ago
- People who still have walking difficulties affecting one side of the body as a result of their stroke (such as an abnormal walking pattern)
- People who are able to walk for 5 minutes at their own pace, with or without a walking aid such as a cane
- People whose walking speed is slower than 1.2 metres per second
- People whose lower limb movement and motor function falls within a specific range on a clinical assessment scale called the Fugl-Meyer Motor Score (a score between 15 and 30) (confirm with trial site)
- People who have at least 5 degrees of upward ankle movement, which is needed to complete a specific ankle movement task used in the trial (confirm with trial site)
Who may not be able to join:
- People with severe osteoporosis
- People whose lower limb movement is significantly limited due to muscle or joint stiffness (contractures)
- People with notably increased muscle stiffness in the ankle, as measured by a clinical scale called the Modified Ashworth Scale (a score above 2) (confirm with trial site)
- People whose anti-spasticity medications (medicines used to reduce muscle stiffness) are not stable or are being changed during the study period
- People with reduced sensation in the lower limb, as measured by the Fugl-Meyer Sensory Assessment Scale (a score below 6) (confirm with trial site)
- People with heart, lung, or metabolic conditions such as irregular heartbeat, uncontrolled high blood pressure, uncontrolled diabetes, or chronic lung disease
- People with unhealed pressure sores or an ongoing infection
- People with significant difficulties with memory, thinking, or communication that may prevent them from understanding or completing the study tasks, as assessed by a cognitive screening tool called the Mini-Mental State Examination (a score below 21) (confirm with trial site)
- People whose stroke affected the brainstem or cerebellum (specific regions at the base and back of the brain)
- People who do not pass a supervised exercise stress test conducted before the trial begins
- People who have an implanted cardiac pacemaker (a device fitted in the chest to regulate heartbeat)
- People who have any metal implants in the head or face
- People who experience unexplained, recurring headaches
- People with a history of seizures or epilepsy
- People currently taking medications that may increase brain excitability or lower the threshold for seizures
- People with skull abnormalities or fractures
- People who have had a concussion within the last 6 months
- People who are currently pregnant
- People with skin sensitivity or allergies that affect the scalp or skin
- People with a history of contact dermatitis (a skin reaction caused by touching certain substances)
- People with a history of allodynia (pain from normally non-painful stimuli) or hyperalgesia (increased sensitivity to pain)
- People with any other skin or scalp condition that could be made worse by electrical stimulation applied to the scalp
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sangeetha Madhavan, University of Illinois at Chicago
Phone: 3123552517
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Walking speed with 10 meter walk test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.